CDCP1 and pancreatic neoplasm: CDCP1 has been identified on cells with phenotypic markers of mesenchymal stem cells or of neural progenitor cells [41], and its expression in pancreatic cancer tissue has been linked to maintenance of cancer stem-cell phenotypes (including gemcitabine resistance) [42].